Treatment of lentigo maligna with tazarotene 0.1% gel.

Abstract

We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.